Organovo’s Merger Deal with Tarveda Falls Through, for Now

It has been a stormy few months for the early-stage medical laboratory and research company Organovo. Since announcing a merger deal with Tarveda Therapeutics, a privately-held clinical-stage biopharmaceutical firm, last…

Former CEO of Organovo Urges Stockholders Against Merger with Tarveda

Gaining a competitive advantage is at the core of most businesses. That is why the financial world has a section dedicated exclusively to study the behind-the-scenes of mergers and acquisitions…

More 3D Printing Executive Transitions as Organovo CEO Keith Murphy Steps Down, to be Replaced by Taylor J. Crouch

This year has been a tumultuous one in the 3D printing industry so far. January saw the resignation of MakerBot CEO Jonathan Jaglom, who was replaced by Nadav Goshen, and…

Paul Gallant Takes GM Slot With 3D Bioprinting Innovators Organovo

Organovo Holdings, Inc. has made waves with their ability to deliver scientific and medical breakthroughs via 3D bioprinting technology. The company’s 3D bioprinting methods enable the automated creation of living…

Organovo Only 4-6 Years Away From 3D Printing Partial Livers For Human Implantation

There are so many areas within the 3D printing space one can get excited about; however, in my opinion one of the most exciting areas is the work being done…

Shock & Awe: Inside 3D Printing Conf. in Santa Clara Provides Incredible Insight, News, Rumors & More

The Inside 3D Printing Conference and Expo is known worldwide as the place to be if you or your company has any interest in the up-and-coming technology of additive manufacturing…


Subscribe To Our Newsletter

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our 3DPrint.com.

You have Successfully Subscribed!